Charles River Laboratories shares surge on strong earnings and analyst upgrades
Charles River Laboratories International Inc. saw its stock jump 11.27% on October 21, 2026 after reporting solid earnings and reaffirming its 2026 EPS guidance at the top of its $11.15‑$11.45 range. The company disclosed annual revenue of about $4.0 billion and quarterly revenue of roughly $1.0 billion, while operating cash flow and free cash flow were $179.7 million and $148.6 million respectively. Analysts upgraded their price targets, with UBS moving to a $357 target and other banks setting targets between $320 and $357.
Why it matters
The higher price targets and bullish sentiment could lift the stock toward the $320‑$357 range, offering upside for traders. The reaffirmed EPS guidance and cash‑flow strength suggest the company is on track to meet its multi‑year growth and margin goals.
Key facts
- 1The stock rose 11.27% on October 21, 2026. stockstotrade.com
- 2Charles River reported annual revenue of $4.0 billion. timothysykes.com
- 3Charles River reported annual revenue of $4.02 billion. timothysykes.com
- 4Quarterly revenue was about $1.00 billion. stockstotrade.com
- 5Operating cash flow was $179.7 million. timothysykes.com
- 6Free cash flow was $148.62 million. stockstotrade.com
Summary written by AlphAI AI Desk from 3 of 3 sources. Not investment advice. Figures are as stated by the linked sources.